Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
United States
Pharma
AstraZeneca plots NYSE listing amid UK industry pullback
The move will replace AZ’s existing U.S. listing of American Depositary Receipts on the Nasdaq, which simplify U.S. investing in foreign companies.
Fraiser Kansteiner
Sep 29, 2025 10:05am
Trump's pharma tariffs offer some relief, many unknowns
Sep 26, 2025 11:16am
Hansa eyes FDA filing after ph. 3 win for kidney transplant med
Sep 25, 2025 12:37pm
Fujifilm Biotechnologies christens $3.2B antibody plant in NC
Sep 24, 2025 1:00pm
Lilly reveals plans for $6.5B API production facility in Texas
Sep 23, 2025 1:00pm
Korea's Celltrion throws down $330M for Lilly plant in N.J.
Sep 23, 2025 9:24am
